A similar observation was made in HCC and CRC mouse models, where addition of recombinant WNT3A to tumor-derived T cells increased expression of β-Catenin and decreased expression of the CTL differentiation marker T-bet. Here, WNT3A is linked to hepatocellular carcinoma.